Evidence map›Paper›PMID 33392355›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2021

Unusual presentation of lumbar chordoma on bone scintigraphy in a young patient.

Yasaman Fakhar, Golnaz Gholami, Zahra Bakhshi Golestani, Ramin Sadeghi, Vahid Reza Dabbagh Kakhki

Open access · greenAbstract readCase Reports
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yasaman FakharNuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran.
Golnaz GholamiNuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran.
Zahra Bakhshi GolestaniNuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran.
Ramin SadeghiNuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran.
Vahid Reza Dabbagh KakhkiNuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran.
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chordoma is a rare bone cancer which arises from undifferentiated notochordal remnants in the axial skeleton. It generally has slow-growing and locally aggressive behavior. This tumor is usually diagnosed by CT and MRI modalities and the role of SPECT/CT is still debated. It shows reduced or normal uptake of radioisotope on bone scanning and increased tracer uptake is infrequently reported. Here we present a 33-year-old man with complaint of low back pain and numbness of his right leg. The whole body bone scan showed relatively uniform radiotracer activity throughout the skeleton. A focal increased uptake in the second lumbar vertebra was noted on SPECT/CT images. SPECT/CT also demonstrated multiple lytic lesions in lumbar vertebrae. The lesions were proven to be chordoma on biopsy. Lumbar chordoma could be one of the differential diagnoses for lytic lesions of the vertebrae which show absent or minimal tracer uptake on bone scintigraphy and SPECT/CT imaging. Our case was unusual as the patient was very young for chordoma diagnosis and bone scan showed increased uptake adjacent to the involved vertebral lesion detected by SPECT/CT.

Indexed as

Bone scintigraphyChordomaLumbar spineNuclear medicineSPECT/CT

Identifiers

PMID33392355
PMCPMC7701223
OpenAlexW3094898136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.